HealthQuill Articles by: HealthQuill
The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study by the National Institutes of Health (NIH).
Drugs Health Pharma

Severe Covid-19 infection can cause heart damage: NIH study says

HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study

Read More
The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.
Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

 HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Health Pharma

AstraZeneca to acquire Fusion Pharmaceuticals for $2 billion in cash

HQ Team March 20, 2024: Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the

Read More
Bayer AG, a German pharmaceutical major, will seek regulatory approval for its menopausal drug after the final trials proved to reduce hot flashes.
Drugs Health Pharma

Bayer’s menopausal drug lowers hot flashes, to seek regulatory nod

HQ Team March 19, 2024: Bayer AG, a German pharmaceutical major, will seek regulatory approval for its menopausal drug after the final trials

Read More
The US Food and Drug Administration has cleared Orchard Therapeutics’s gene therapy to treat a disease affecting the brain and nervous system in children — the regulator’s first ever for the disorder.
Drugs Health Pharma

FDA green lights first-ever therapy for rare genetic disease in kids

HQ Team March 19, 2023: The US Food and Drug Administration has cleared Orchard Therapeutics’s gene therapy to treat a disease affecting the

Read More
The entire population in the Gaza Strip, 2.23 million, is facing food insecurity and by mid-July half of the residents may experience catastrophic hunger, according to a report.
Drugs Health Pharma

Gaza Strip hurtling toward imminent famine, a global alliance says

HQ Team March 19, 2024: The entire population in the Gaza Strip, 2.23 million, is facing food insecurity and by mid-July half of

Read More
Teenage is the time of celebrity worship syndrome, fandom and social media influence. This age group is highly susceptible to media influence due to preoccupation with identity, making them identify with and model what they view. 
Drugs Health Opinion Pharma

Opinion: Time for young celebrity idolators to turn reels into reality

By Aparna S March 19, 2024: Substance use disorder is a major public health problem across the globe, and India is no exception.

Read More
Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease burden ahead of cardiovascular diseases, according to an analysis.
Drugs Health Pharma

Neurological conditions top global cause of disease burden

HQ Team March 18, 2023: Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease

Read More
At least 57 women and girls in Sudan were at the receiving end of sexually-related violence since a conflict between warring factions of the military government in the country began in April, the UN stated.
Drugs Health Medical

Female genital mutilation sees a 15% increase worldwide; UNICEF

HQ Team March 18, 2024: There are over 230 million victims of female genital mutilation worldwide, according to the UNICEF. This is an

Read More
Gene editing technology called CRISPR can help diagnose nontuberculous mycobacteria infections in less than two hours from six months, researchers found.
Drugs Health Pharma

Gene-editing cuts diagnosis time for mycobacteria infection

HQ Team March 18, 2024: A gene editing technology called CRISPR can help diagnose nontuberculous mycobacteria infections in less than two hours from

Read More